Vaccines, COVID-19, and Myeloma with Dr. Mike Thompson
With new COVID-19 vaccinations, many of us within the Myeloma Community have questions about how it will affect us. Come hear from an expert, Dr. Mike Thompson, as he presents on infections, vaccines, and antibiotics for myeloma patients, then take the opportunity to ask Dr. Thompson any questions you may have.
Jennifer Ahlstrom
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.
Michael A. Thompson, MD, Ph.D.
Michael A. Thompson, MD, Ph.D. is the Medical Director for the Early Phase Cancer Research Program, Patient-Centered Research at the Aurora Research Institute. He is an active clinical researcher whose interests include hematologic or blood cancers (lymphoma, myeloma, leukemia, and myelodysplastic syndrome). He is also interested in developing new treatments for all cancers, particularly early phase (Phase I and II) molecular biomarker-driven clinical trials. In addition, he is extensively published and serves as a reviewer for multiple scientific publications.